MNPR
Monopar Therapeutics Inc.$103.93-4.39 (-4.05%)Prev Close$108.32·MCap$736.6M·P/E—·Vol63.9K·Yield—
▲
Buys (12M)
1
$104.9K
▼
Sells (12M)
8
$1.81M
◆
Net Activity
Net Seller
$1.71M
●
Active Insiders
7
last 12 mo
Over the past 12 months, insider activity at Monopar Therapeutics Inc. (MNPR) has been dominated by selling, with 1 insider purchase totaling $104.9K and 8 insider sales totaling $1.81M. The most recent insider transaction was by Anderson Raymond (director), who sold $351.2K worth of shares on Aug 27, 2026. Monopar Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $736.6M.
MNPR Insider Trading Activity
MNPR Insider Buying Activity
The following table shows recent insider purchases of Monopar Therapeutics Inc. (MNPR) stock reported via SEC Form 4 filings.
MNPR Insider Selling Activity
The following table shows recent insider sales of Monopar Therapeutics Inc. (MNPR) stock reported via SEC Form 4 filings.